Unbound MEDLINE

[Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm] Revista española de anestesiología y reanimación [Rev Esp Anestesiol Reanim] Journal article

 
Title[Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm]
Author(s)Varela CA, Gómez JM, Reina MA, López A, Galindo S, Arruga AM 
InstitutionServicio de Anestesia, Hospital Universitario de Madrid-Montepríncipe, Madrid. carlosvarelac@yahoo.es
SourceRev Esp Anestesiol Reanim 2009 Apr; 56(4):245-8.
AbstractA 66-year-old man with a metallic valve and under treatment with acenocoumarol developed hypovolemic shock after rupture of a splenic artery pseudoaneurysm. We managed to reverse anticoagulation within 60 minutes by administering 20 mg of vitamin K and 4.8 mg of activated recombinant factor VII. No thromboembolic adverse events were observed. We discuss the pharmacologic effects of coumarin derivatives and their antagonists, as well as the use of activated factor VII in the reversal of anticoagulation by these drugs.
Languagespa
Pub Type(s)English Abstract
Journal Article
PubMed ID19537265
  
Advertise on this site.